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both from the spread of this phenomenon and 
from the losses it causes to the societies and 
economies of individual countries.6 According to 
the World Health Organization (WHO), the num‑
ber of deaths caused by smoking ‑related diseas‑
es exceeded 100 million in the 20th century.7,8 As 
regards Poland, every year approx. 70 000 deaths 
INTRODUCTION The health consequences of to‑
bacco smoke exposure have been long known.1,2 
Tobacco smoking is one of the main risk factors 
for death and diseases such as cancer, coronary 
artery disease, stroke, and noncancerous respira‑
tory diseases,3-5 as well as one of the most impor‑
tant threats to modern civilization. This results 
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ABSTRACT
INTRODUCTION The reduction of tobacco smoking remains a challenge for public health.
OBJECTIVES The main purpose of this study was to evaluate changes in the prevalence and patterns 
of tobacco use in the adult population of Poles in the years from 2003 to 2014. Furthermore, changes in 
the smoking addiction, the declared reasons for smoking, as well as readiness and motivation to stop 
smoking were assessed.
PATIENTS AND METHODS Based on data from the Polish studies WOBASZ and WOBASZ II, the analysis 
included 14 576 participants from the first study (6906 men and 7670 women) and 5696 participants 
from the second study (2578 men and 3118 women), aged between 20 and 74 years.
RESULTS According to the WOBASZ II study, 30% of men and 21% of women in Poland smoked, the rates 
being 9% and 4% lower for men and women, respectively, in comparison with the WOBASZ study 
(P <0.001). The average number of cigarettes smoked daily per smoker significantly decreased during 
the follow ‑up period among men (from 17.9 to 15.8 cigarettes per day) and women (from 13.7 to 12.1 
cigarettes per day). The percentage of men who never smoked increased from 29.8% to 36.1% (P <0.0001), 
while the proportion of women who never smoked did not change. However, the percentage of those 
expressing unwillingness to quit smoking nearly doubled in WOBASZ II in comparison with WOBASZ.
CONCLUSIONS Although the smoking rates in Poland have declined over the past decade, smoking 
remains prevalent among men and women. Therefore, it is necessary to optimize tobacco control in 
Poland, including fiscal policy, counseling and tobacco addiction treatment, as well as promotional and 
educational activities, with a special emphasis on the female population.
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former smokers, and nonsmokers. A smoker was 
defined as a person who at the time regularly 
smoked at least 1 cigarette a day; an occasional 
smoker was defined as a person who smoked less 
than 1 cigarette a day; a former smoker was a per‑
son who had smoked in the past, stopped smok‑
ing, and did not smoke at the time of the survey; 
and a nonsmoker was a person who had never 
smoked cigarettes. Cigarette count was consid‑
ered as the number of cigarettes smoked per per‑
son per day. The reasons for tobacco smoking were 
classified on the basis of the questionnaire into 
the following categories: social smoking, for plea‑
sure, “it calms me down,” out of habit, other, hard 
to say. The possible categories for answers to as‑
sess the willingness to quit smoking were as fol‑
lows: yes, no, undecided. For more in ‑depth anal‑
yses, the respondents were classified into 5 age 
groups: between 20 and 34, 35 and 44, 45 and 
54, 55 and 64, and 65 and 74 years.
In the presentation of the results, the following 
descriptive statistics were used: rates of the occur‑
rence of individual phenomena in the age groups, 
age standardized rates according to the structure 
of the Polish population as of December 31, 2013, 
crude means and age ‑adjusted means. For the pur‑
pose of comparing the rates between the stud‑
ies and between age groups, the χ2 test was used. 
The differentiation of standardized rates was ana‑
lyzed by setting 95% confidence intervals. The Wil 
coxon test was used to compare the age of start‑
ing smoking and the numbers of smoked ciga‑
rettes between the age groups. The smoking sta‑
tus was differentiated between the studies based 
on the significance of the odds ratio.
All the analyses were carried out separately for 
men and women, using the statistical SAS version 
9.2 (SAS Institute, Cary, North Carolina, United 
States). A P value of less than 0.05 was consid‑
ered statistically significant.
RESULTS In the WOBASZ and WOBASZ II stud‑
ies, men declared themselves as regular smokers 
more often than women (TABLE 1). In the WOBASZ 
survey, regular smoking was declared by 39.0% of 
men and 23.8% of women. As regards WOBASZ II, 
the prevalence of regular tobacco smoking was 
29.9% among men and 20.5% among women. 
Over a decade, the percentage of adult smok‑
ers aged between 20 and 74 years significant‑
ly declined in Poland, both for men and women 
(P <0.001). An increase in the proportion of never‑
‑smoking men was also observed, from 29.8% to 
36.1% (P <0.0001).
In both surveys, smoking differed widely be‑
tween age groups for men and women (TABLE 2). 
During the follow ‑up, there was a significant de‑
crease in the proportion of smoking men in ev‑
ery age group, and there were significantly few‑
er smoking women in the age group of 35 to 44 
years. In both surveys, the most frequent smok‑
ers were middle ‑aged men and women. The low‑
est number of smoking people in both studies, 
for men and women alike, was found in the group 
are caused by smoking.9,10 In 2004 tobacco smok‑
ing accounted for 47% of all deaths caused by tu‑
mors among men, and it was the main cause of 
lung cancer among men aged 30 years or older. 
Among women in the same age group, 13% of tu‑
mor deaths and 73% of all deaths due to lung can‑
cer were also related to tobacco use.9,10 The treat‑
ment of patients with tobacco ‑related diseases 
generates a significant part of the cost of health 
care services in Poland and imposes a considerable 
burden on the organization of the health care sys‑
tem. Long ‑term, expensive diagnostic procedures 
and treatment of diseases related to the use of to‑
bacco products account for around 18 billion PLN 
(6.4 billion USD) annually. Losses in work produc‑
tivity and employment, including disability and 
disability benefits, caused by the use of tobacco 
products are estimated to exceed 15 billion PLN 
(5.3 billion USD) every year.7,11
The reduction of tobacco consumption and of 
associated costs is one of the biggest challenges 
for public health. Regular monitoring of various 
aspects of tobacco epidemic can provide reliable 
and effective tools to fight this threat at the sys‑
temic level. Data from epidemiological studies are 
the basis for a reasonable health policy.
The main purpose of this study was to evalu‑
ate changes in the prevalence of tobacco smoking 
among the adult population of Poles in the period 
between 2003 and 2014. Furthermore, changes 
in the smoking habits, the declared reasons for 
smoking, as well as readiness and motivation to 
stop smoking were assessed.
PATIENTS AND METHODS The results were ob‑
tained from the Polish Nationwide Studies of 
Health Assessment, WOBASZ and WOBASZ 
II, which were repeated cross ‑sectional sur‑
veys. The  first WOBASZ study was conduct‑
ed between 2003 and 2005, and the  sec‑
ond (WOBASZ II)—between 2013 and 2014. 
The methods, including the rules of sampling, 
the tools used, the research protocol, and the prin‑
ciples of project implementation, were described 
in detail previously.12,13 The survey data were col‑
lected in direct interviews by adequately trained 
interviewers. The first and second studies covered 
14 769 and 6170 respondents, respectively. The to‑
tal participation rate was 74.6% for WOBASZ and 
46.4% for WOBASZ II. After deleting incomplete 
records, the analysis included a sample of 14 576 
participants (6906 men and 7670 women) from 
the first study and 5696 participants (2578 men 
and 3118 women) from the second study, all aged 
between 20 and 74 years. The information col‑
lected in the studies comprised the respondents’ 
socio ‑demographic data and smoking character‑
istics such as the age of starting smoking, rea‑
sons for smoking, number of cigarettes smoked 
daily, intention to quit smoking, and motivations 
to stop smoking among smokers.
Participants in the survey were divided ac‑
cording to their smoking status into the follow‑
ing groups: regular smokers, occasional smokers, 
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significantly decreased in the follow ‑up period 
both for men (17.9–15.8 cigarettes/day) and for 
women (13.7–12.1 cigarettes/day). Among men 
smokers, the most cigarettes were smoked in 
the age group between 35 and 54 years. Among 
smoking women, in the first study the most cig‑
arettes were smoked in the age group between 
45 and 54 years, whereas in the second survey it 
concerned the oldest group under analysis, aged 
between 65 and 74 years (P >0.0005). The lowest 
average number of consumed cigarettes per smok‑
er was observed in the youngest age group (20–34 
years) in both studies for men and women alike.
The average age of starting regular smoking in‑
creased in the second study in comparison with 
the first study by about 2 years among men (18 
vs 20 years) and also by about 2 years among 
women (20 vs 22 years; P <0.05). Data are pre‑
sented in TABLE 4.
The most frequently declared reason for cur‑
rent tobacco smoking by men and women in both 
studies was the force of habit (TABLE 5), followed 
by the calming effect of smoking, “for pleasure”.
of oldest participants aged between 65 and 74 
years. The tendency to quit smoking can be as‑
sessed to have increased as the participants from 
a selected age group in the first study moved to 
the next age group in the second study. Over 10 
years, the percentage of smoking participants 
in the group aged between 35 and 44 years in 
the first study and in the group aged between 45 
and 54 years in the second study decreased by 
about 9%. As for the other groups, an increasing 
tendency for men to quit smoking with age could 
be observed, whereas the opposite was true for 
women: there was an increase in the percentage 
of smoking women in the age groups between 
55 and 64 years and 65 and 74 years. The distri‑
bution of motivations for smoking shows that 
over 10 years the percentage of women declar‑
ing the reason for smoking as “for pleasure” rose 
by 11% (for men a marked increase was also ob‑
served but it was smaller).
On average, men smoked more cigarettes 
per day than women (TABLE 3). The  average 
number of cigarettes smoked daily per smoker 
TABLE 1 Distribution of the smoking status (%) in WOBASZ II vs WOBASZ studies
Smoking 
status
Men Women
WOBASZ, n = 6906 WOBASZ II, n = 2578 OR
P value
WOBASZ, n = 7670 WOBASZ II, n = 118 OR
P valuen % (95% CI) n % (95% CI) n % (95% CI) n % (95% CI)
never smoker 2058 29.8
(28.7–30.9)
930 36.1
(34.2–37.9)
1.33
<0.0001
4386 57.2
(56.1–58.3)
1823 58.5
(56.8–60.2)
1.05
0.2216
former smoker 1910 27.7
(26.6–28.7)
799 31.0
(29.2–32.8)
1.17
0.0014
1175 15.3
(14.5–16.1)
574 18.4
(17.0–19.8)
1.25
<0.0001
occasionally 
smoker
247 3.6
(3.2–4.0)
78 3.0
(2.3–3.7)
0.83
0.1894
285 3.7
(3.3–4.1)
82 2.6
(2.0–3.2)
0.69
0.0048
regularly
smoker
2691 39.0
(37.8–40.1)
771 29.9
(28.1–31.7)
0.67
<0.0001
1824 23.8
(22.8–24.7)
639 20.5
(19.1–21.9)
0.83
0.0002
Abbreviations: CI, confidence interval; n, number of patients; OR, odds ratio
TABLE 2 Prevalence of smokers (%) in age groups in WOBASZ II vs WOBASZ studies
Age 
group, 
y
Men Women
WOBASZ WOBASZ II OR
P value
WOBASZ WOBASZ II OR
P valuen % (95% CI) n % (95% CI) n % (95% CI) n % (95% CI)
20–34 751 39.5
(37.0–41.4)
205 31.7
(27.9–35.1)
0.71
0.0415
480 21.8
(19.9–23.3)
131 18.1
(15.3–20.9)
0.80
0.3568
35–44 560 45.0
(42.0–47.6)
158 30.4
(26.4–34.3)
0.53
0.0211
492 35.1
(32.4–37.4)
110 18.3
(15.2–21.4)
0.42
<0.0001
45–54 769 45.6
(42.8–47.6)
180 35.9
(31.7–40.1)
0.67
0.0182
593 32.5
(28.7–36.3)
174 26.3
(19.8–32.8)
0.75
0.1203
55–64 399 36.3
(33.4–39.0)
170 29.6
(25.9–33.3)
0.74
0.1233
207 17.2
(12.1–22.3)
183 25.0
(21.9–28.1)
1.6
0.0585
65–74 212 22.7
(20.0–25.4)
58 17.5
(13.4–21.6)
0.72
0.3937
52 5.2
(3.8–6.6)
41 10.3
(7.3–13.3)
2.09
0.3524
75–84 – – 24 15.9
(10.1–21.7)
– – 7 3.0
(0.8–5.2)
–
SR
20–74
2691 39.2
(36.8–41.6)
771 29.9
(26.3–34.1)
0.66
<0.05
1824 23.9
(21.3–25.9)
639 20.5
(16.5–23.7)
0.82
>0.05
Abbreviations: SR, standardized frequency for age; others, see TABLE 1
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strengths included a wide range, a large sample 
size, and the representativeness of the obtained 
data for Poland’s adult population. The age dis‑
tributions in the randomly selected survey sam‑
ples of WOBASZ and WOBASZ II were not sig‑
nificantly different. Moreover, the same ques‑
tionnaire was used for both studies. Such a se‑
lection of research tools allowed obtaining fully 
comparable data. 
The studies also had some limitations. The par‑
ticipation rates for WOBASZ and WOBASZ II 
ranged from around 75% to 47%, which is a re‑
sult comparable to other epidemiological studies 
conducted earlier in Poland and ensures the cred‑
ibility and reliability of obtained data.14 However, 
the results of the studies are only based on a sur‑
vey questionnaire, which can lead to underestima‑
tion or overestimation of the findings. The analy‑
sis used no objective methods for verifying the to‑
bacco smoking status of the respondents. How‑
ever, it should be emphasized that such a study 
would require specialized equipment, appropri‑
ate logistic preparation and considerable finan‑
cial resources. Survey methods are relatively in‑
expensive and allow for a relatively easy data col‑
lection and for examination of a large number of 
respondents, while proving to be reliable tools in 
most epidemiological studies.15,16
A large number of smokers, both men and wom‑
en, declared the will to stop smoking (TABLE 6). The 
willingness to quit smoking was declared by more 
than 70% of the respondents. However, this per‑
centage decreased by almost 10% in both groups 
in comparison with the period from 2003 to 2005. 
At the same time, the percentage of those express‑
ing unwillingness to quit smoking nearly doubled 
in WOBASZ II compared with WOBASZ.
The most common reason (around 40% of 
the participants) for quitting smoking among 
smokers in both studies for men and women 
alike was the fear of illness (TABLE 7). The second 
most frequent reason for stopping smoking was 
the financial aspect (over 20% of participants in 
both studies). However, it must be noted that in 
the case of both the “fear of illness” and “finan‑
cial aspects” the proportion of those motivations 
in the reasons for quitting smoking showed no 
change during the follow ‑up period. Other rea‑
sons proved to be far less important. Doctor’s or‑
ders as a reason for quitting smoking was only in‑
dicated by 3% of the men and women surveyed 
in both studies.
Study strengths and limitations WOBASZ and 
WOBASZ II were descriptive, cross ‑sectional, 
population ‑based, epidemiological studies. Their 
TABLE 3 The average of smoked cigarettes per day in smokers in WOBASZ II vs WOBASZ studies
Age
group, y
Men Women
WOBASZ WOBASZ II P value WOBASZ WOBASZ II P value
mean values (95% CI)
median (range)
mean values (95% CI)
median (range)
mean values (95% CI)
median (range)
mean values (95% CI)
median (range)
20–34 15.4 (14.9–15.8)
15 (1–50)
12.8 (11.9–13.8)
10 (2–45)
<0.05 12.0 (11.4–12.5)
10 (1–30)
10.4 (9.4–11.4)
10 (1–30)
0.05
35–44 19.6 (19.0–20.3)
20 (2–50)
17.1 (15.8–18.5)
20 (2–60)
<0.05 14.1 (13.5–14.7)
15 (1–40)
12.5 (11.3–13.8)
10 (1–30)
>0.05
45–54 19.4 (18.8–19.9)
20 (2–60)
17.6 (16.3–18.8)
20 (1–60)
0.05 14.5 (13.9–15.0)
15 (1–40)
12.7 (11.6–13.7)
10 (1–40)
<0.05
55–64 18.3 (17.4–19.2)
20 (1–80)
16.8 (15.4–18.2)
20 (1–60)
>0.05 14.2 (13.2–15.2)
15 (1–40)
12.2 (11.2–13.1)
10 (1–30)
<0.05
65–74 15.7 (14.5–16.8)
15 (1–50)
14.4 (12.1–16.6)
15 (1–40)
>0.05 13.6 11.4–15.8)
10 (3–40)
13.8 (10.9–16.6)
10 (4–40)
>0.05
total 17.9 (17.5–18.1)
20 (1–80)
15.8 (15.2–16.4)
15 (1–60)
<0.05 13.7 (13.4–14.0)
13 (1–40)
12.1 (11.6–12.6)
10 (1–40)
<0.05
Abbreviations: see TABLE 1
TABLE 4 The average age of smokers at the beginning of regular smoking in WOBASZ II vs WOBASZ studies
Age Men P value Women P value
WOBASZ, n = 2692 WOBASZ II, n = 761 WOBASZ, n = 1825 WOBASZ II, n = 634
mean age (SD)
(95% CI)
median (range)
mean age (SD)
(95% CI)
median (range)
mean age (SD)
(95% CI)
median (range)
mean age (SD)
(95% CI)
median (range)
age of 
starting 
smoking
18.3 (3.7)
(18.1–18.4)
18 (6–65)
19.7 (5.1)
(19.3–20.0)
19 (7–65)
<0.05 20.3 (5.0)
(20.1–20.5)
19 (7–58)
21.9 (6.4)
(21.4–22.4)
20 (12–63)
<0.05
Abbreviations: see TABLE 1
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tobacco consumption control policies. In most Eu‑
ropean countries, as in Poland, men are more fre‑
quent smokers. The differences between the pro‑
portions of smoking men and women are minor 
in the countries of northern and western Eu‑
rope, whereas they are larger in central and east‑
ern Europe.
Poland belongs to a group of countries with 
a high prevalence of smoking, both among men 
and women.23 In the POLSCREEN (2002–2005) 
study,24 among the population of people aged 35 
years or older reporting to a doctor, the preva‑
lence of smoking compared to the WOBASZ study 
was lower—27.3% for men and 14.3% for women.
Similarly, a lower percentage of smoking women 
(16.7%) was recorded in the “Taking care of heart” 
study.25 In contrast, the NATPOL 2011 survey, 
which included a population of similar age to that 
in WOBASZ (18–79 years), indicated a compara‑
ble number of smoking men (31.5%) and more 
female smokers (27.5%) than WOBASZ.26 Com‑
parable results were also obtained in the Polish 
part of the Global Adult Tobacco Survey (GATS) 
study conducted from 2009 to 2010, which cov‑
ered a population aged 15 years or older, where 
DISCUSSION The prevalence of tobacco smok‑
ing and its intensity vary in the world according 
to the development phase of the tobacco epidem‑
ic in a given region.17-22 The countries character‑
ized by the highest prevalence of tobacco smoking 
among men also included the countries of Cen‑
tral and East Asia as well as of central and eastern 
Europe (above 50%). Inhabitants of Africa, North 
and South America, and northern, western, and 
southern Europe smoked much less (10%–20%).7 
The prevalence of tobacco smoking among men 
in Europe in such countries as Russia, Ukraine, 
Latvia, Bulgaria, and Greece was 50% or higher, 
while the lowest prevalence was observed among 
men in Sweden and England (below 20%). Wom‑
en in Poland, Russia, Bulgaria, and Greece smoked 
most often (above 30%). The lowest number of 
smoking women was observed in Sweden, Roma‑
nia, and Lithuania (below 20%).18,19
The differences in the prevalence of tobacco 
smoking between countries and between men and 
women within individual countries can be con‑
ditioned by culture, customs, the types of com‑
monly used products containing nicotine, but also 
by the range and effectiveness of implemented 
TABLE 5 Declaration of the smoking reasons (% of smokers) in WOBASZ II vs WOBASZ studies
Reason of 
smoking
Men Women
WOBASZ WOBASZ II OR
P value
WOBASZ WOBASZ II OR
P valuen %
(95% CI)
n %
(95% CI)
n %
(95% CI)
n %
(95% CI)
social 
smoking
53 2.0
(1.5–2.5)
31 4.0
(2.6–5.4)
2.04
<0.05
51 2.8
(2.0–3.6)
22 3.4
(2.0–4.8)
1.22
>0.05
for pleasure 210 7.8
(6.8–8.8)
117 15.2
(12.7–17.7)
2.12
<0.05
201 11.0
(9.6–12.4)
143 22.4
(19.2–25.6)
2.34
<0.05
it calms me 
down
579 21.5
(19.9–23.0)
189 24.5
(21.5–27.5)
1.18
>0.05
553 30.3
(28.2–32.4)
164 25.7
(22.3–29.1)
0.80
>0.05
out of habit 1715 63.7
(61.9–65.5)
358 46.4
(42.9–49.9)
0.49
<0.05
924 50.6
(48.3–52.9)
248 38.9
(35.1–42.7)
0.62
<0.05
other 41 1.5
(1.0–2.0)
9 1.2
(0.4–2.0)
0.80
>0.05
25 1.4
(0.9–1.9)
10 1.6
(0.6–2.6)
1.15
>0.05
hard to say 93 3.5
(2.8–4.2)
67 8.7
(6.7–10.7)
2.63
<0.05
71 3.9
(3.9–4.8)
50 7.9
(5.8–10.0)
2.11
<0.05
Abbreviations: see TABLE 1
TABLE 6 Declaration to stop smoking (% of smokers) in WOBASZ II vs WOBASZ studies
Declaration to 
stop 
smoking
Men Women
WOBASZ WOBASZ II OR
P value
WOBASZ WOBASZ II OR
P valuen %
(95% CI)
n %
(95% CI)
n %
(95% CI)
n %
(95% CI)
yes 2290 85.2
(83.9–86.5)
576 74.7
(71.6–77.8)
0.51
<0.05
1515 83.0
(81.3–84.7)
480 75.1
(71.7–78.4)
0.62
<0.05
no 178 6.6
(5.7–7.5)
90 11.7
(9.4–14.0)
1.88
<0.05
135 7.4
(6.2–8.6)
73 11.4
(8.9–13.9)
1.61
<0.05
I haven’t 
decided
221 8.2
(7.2–9.2)
105 13.6
(11.2–16.0)
1.76
<0.05
175 9.6
(8.2–10.9)
86 13.5
(10.8–16.1)
1.47
>0.05
Abbreviations: see TABLE 1
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smoker. Greece, Ireland, Italy, France, Switzerland, 
and countries of eastern Europe, including Russia, 
are the European countries with high consump‑
tion of cigarettes, where people smoke above 20 
cigarettes a day. People in Sweden, Estonia, and 
the Netherlands smoked the lowest amount of cig‑
arettes (below 20 a day).19,21,30 The POLSCREEN 
study24 reported an  average of 16 cigarettes 
smoked daily by men and 13 by women, which 
is consistent with the results of the WOBASZ II 
survey. Similar values were obtained in other Pol‑
ish studies.14,29,31 Interesting findings included 
the relationship between the number of smoked 
cigarettes and age, as well as a decrease in ciga‑
rette consumption over the period of 10 years.
Beginner smokers usually smoke a small num‑
ber of cigarettes daily, increasing this number 
with the duration of the habit and their increas‑
ing addiction to nicotine, whereas people of old‑
er age (around 60 years) favor reduction and ces‑
sation of smoking, which is consistent with find‑
ings from other studies.32,33 The most common in‑
terpretation of this relationship is that with age 
the health of participants worsens and the in‑
cidence of symptoms (including symptoms of 
tobacco ‑related diseases) increases, which may 
encourage smokers to reduce their tobacco con‑
sumption.33,34 The reduction in the number of 
cigarettes smoked by men observed in the old‑
er age groups in the WOBASZ and WOBASZ II 
studies is promising, but we cannot exclude that 
it is partly associated with the rapidly growing 
interest in and prevalence of e ‑cigarettes avail‑
able on the Polish market since 2008.35-37 This 
may reduce the number of traditional cigarettes 
smoked. According to the study on the use of 
e ‑cigarettes from 27 European countries among 
smoking men constituted 37.3% and smoking 
women—28.2%.27
The  WOBASZ study showed a  decrease in 
the prevalence of smoking both for men and 
women, but the  decrease was much steeper 
among men than among women. According to 
the NATPOL study,26 in the period from 2001 
to 2011 a similar decrease in the prevalence of 
smoking was found—by 12% for men and 3% 
for women.
In the majority of the world’s most advanced 
economies, the number of smokers is on the de‑
crease.7 According to the WHO,28 in the period 
from 2000 to 2010 the prevalence of smoking 
among men and women decreased in 125 coun‑
tries (72%) and 156 countries (88%), respectively. 
If such trends persist, in 2025 there will be an es‑
timated 1.1 billion smokers in the world. Accord‑
ing to the WOBASZ II study, in Poland smoking 
mostly concerns the middle ‑aged population. Sim‑
ilar results were obtained in the NATPOL 2011 
study26 as well as in other Polish studies.14,29
In the GATS study conducted in Poland in 
the years from 2009 to 2010,27 most men and 
women smoked in the age group between 30 
and 39 years (above 30%). Similarly, the survey 
showed the lowest prevalence of smoking among 
people below 20 years of age. At the same time, 
the high prevalence of tobacco smoking among 
women of childbearing age, in the age group be‑
tween 20 and 40 years, is alarming. Therefore, 
the high proportion of smokers in this group can 
also significantly influence the health of future 
generations.
The world populations are characterized by sig‑
nificant differences in tobacco smoking intensity 
measured by the number of cigarettes smoked per 
TABLE 7 Declaration of the reason to stop smoking (% of smokers) in WOBASZ II vs WOBASZ studies
Reason to stop 
smoking
Men Women
WOBASZ WOBASZ II OR
P value
WOBASZ WOBASZ II OR
P valuen %
(95% CI)
n %
(95% CI)
n %
(95% CI)
n %
(95% CI)
current complaints 122 6.4
(5.3–7.5)
49 8.5
(6.2–10.8)
1.36
>0.05
69 5.5
(4.2–6.8)
33 6.9
(4.6–9.2)
1.27
>0.05
fear of illness 812 42.4
(40.2–44.6)
216 37.5
(33.5–41.5)
0.82
>0.05
531 42.1
(39.4–44.8)
207 43.1
(38.7–47.5)
1.04
>0.05
medical 
recommendations
64 3.3
(2.5–4.1)
19 3.3
(1.8–4.8)
1.00
>0.05
39 3.1
(2.1–4.1)
16 3.3
(1.7–4.9)
1.07
>0.05
friends’ insistence 5 0.3
(0.1–0.5)
0 0 – 4 0.3
(0–0.6)
0 0 –
family’s wish 96 5.0
(4.0–6.0)
51 8.9
(6.6–11.2)
1.86
<0.05
75 6.0
(4.7–7.3)
23 4.8
(2.9–6.7)
0.79
>0.05
financial aspects 443 23.1
(21.2–25.0)
145 25.2
(21.7–28.7)
1.12
>0.05
301 23.9
(21.5–26.3)
116 24.2
(20.4–28.0)
1.02
>0.05
firm resolution 315 16.4
(14.7–18.1)
76 13.2
(10.4–16.0)
0.78
>0.05
196 15.6
(13.6–17.6)
71 14.8
(11.6–18.0)
0.94
>0.05
other 59 3.1
(2.3–3.9)
20 3.5
(2.0–5.0)
1.13
>0.05
45 3.6
(2.6–4.6)
14 2.9
(1.4–4.4)
0.80
>0.05
Abbreviations: see TABLE 1
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could be also due to easy access to tobacco prod‑
ucts, low prices, advertising, and promotion, 
which constitute the front line action of the to‑
bacco industry to maintain and increase the num‑
ber of their customers.42,43 Aggressive market‑
ing may also be responsible for the increase in 
the percentage of women declaring the “for plea‑
sure” category as the reason for smoking. It could 
also be a reason for the lack of interest in quit‑
ting tobacco smoking. It is difficult to unambig‑
uously answer the question why women did not 
change their health behavior. Increasing addic‑
tion of smokers (TABLE 6) and the minor propor‑
tion of doctor’s orders among the reasons for 
quitting smoking are attributable to low efficacy 
of educational activities and insufficient involve‑
ment of medical professionals in the diagnostic 
and therapeutic process. As emphasized by Zhu 
et al,44 the so called “minimal intervention”—doc‑
tors recommending their patients to quit smok‑
ing at any visit—is the easiest approach that may 
significantly increase the rates of smoking cessa‑
tion. This intervention is crucial for public health 
and it is important to maximize its effectiveness 
by offering professional help in quitting smoking 
(for example, medicines or behavioral support), 
which in turn increases the percentage of success‑
ful attempts to quit smoking.45,46 The scope of as‑
sistance in smoking cessation and in the mainte‑
nance of tobacco abstinence must be expanded 
to increase the percentage of nonsmoking peo‑
ple in Poland.
The results of the WOBASZ and WOBASZ II 
studies also demonstrated a limited efficiency 
of fiscal policy and price control in reducing to‑
bacco use. The financial aspects were indicated 
by about 25% of smokers as the reason for quit‑
ting smoking, but this percentage showed no 
change in 10 years. Surprisingly, no change oc‑
curred despite the fact that an increased excise 
tax on tobacco products leading to their higher 
prices is considered to be one of the most effec‑
tive tools used to limit the spread and use of to‑
bacco products.47 In response to growth in taxa‑
tion, new cheap brands of cigarettes were creat‑
ed. Moreover, recent years have been character‑
ized by an increase in the sales of other types of 
tobacco. In addition, in the past decade, despite 
the rise in prices, the availability of cigarettes 
in Poland increased due to the upward trend of 
household income.48
Other implemented measures designed to 
limit the tobacco epidemic in Poland also face 
a number of difficulties. Firstly, cigarette smok‑
ing is firmly anchored in popular culture as well 
as in moral standards. Smoking is often closely 
related to the conditions of spending free time 
as well as to selected professions. Secondly, con‑
trary to the general belief, the population lacks 
sufficient knowledge on the topic of health con‑
sequences of tobacco use.49 Moreover, doctors 
have inadequate training to provide counseling 
and treat addiction related to tobacco smoking. 
They lack the time, and the procedures are not 
the population of 15 years of age and older, e ‑ciga‑
rettes are used by 20.3% (in Poland 31%) of smok‑
ers, most often among the young (15–24 years). 
So far only several studies on e ‑cigarette use in Po‑
land have been conducted. Mostly, those are stud‑
ies related to the youth. In Poland, over the last 
few years, a nearly 5 ‑fold increase in the frequen‑
cy of e ‑cigarette use was observed among teens, 
mostly among boys. It is not absolutely certain, 
but young people seem to be more willing to use 
e ‑cigarettes than traditional cigarettes.35-37
The current prevalence of tobacco smoking and 
the state of the tobacco epidemic in the popula‑
tion is a result of different processes such as ini‑
tiation, continuation, and quitting tobacco smok‑
ing. The average age of smoking initiation de‑
pends on the country, income, education, or age 
of the respondents.38 Smokers from Spain, Den‑
mark, Portugal, and England reach for cigarettes 
at the youngest age (before 17 years old), while 
smokers from Greece, Estonia, and Lithuania be‑
gin to smoke at the oldest age (19 years old).30
In Poland, in the GATS study, the average age 
of initiation of regular smoking was 18.4 (SD, 3.6) 
years for men and 20.0 (SD, 4.7) years for women 
(P <0.01).39 In 2010 in other countries, the aver‑
age age of smoking initiation among women was 
17.1 years in Sweden, 17.9 years in Ireland, 18.1 
years in France, 18.6 years in Italy, and 19.6 years 
in the Czech Republic. Sweden had the highest 
percentage of women who started smoking at a 
very young age, 29.3% declared starting smoking 
between 14 and 15 years of age and 12.0% start‑
ed smoking before the age of 14. The Czech Re‑
public was characterized by the lowest percent‑
age of early smoking initiation—13.7% of the re‑
spondents started smoking at the age between 
14 and 15 years and 1.4% started smoking at the 
age of less than 14 years old. The highest percent‑
age of women declared starting smoking between 
16 and 17 years of age in all countries but Swe‑
den. According to the GATS study,19 women also 
began smoking at a later age than men. Men be‑
come smokers when they are younger than 17 
in Ukraine and England, and when they are old‑
er than 20 in China, India, and Vietnam. Wom‑
en start smoking when they are younger than 17 
in England, and when they are more than 20 in 
most of other countries. The differences in re‑
spondents’ age of smoking initiation in various 
countries may reflect the phases of the tobacco 
smoking epidemic in individual countries and 
the differences in the tobacco control measures.
According to the WOBASZ II study, most of 
the respondents began smoking at around 20. 
Women started smoking later than men, and, im‑
portantly, the age of regular smoking initiation 
in both groups has increased. However, the lack 
of change in the percentage of women who nev‑
er smoke is worth noting.40 The emancipation of 
women and their higher earnings, thus increased 
purchasing power with regard to goods, including 
tobacco products, might have had an impact on 
smoking patterns among women.41 Moreover, it 
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well evaluated in terms of the cost and are under‑
financed. Also teachers are not regularly trained 
in the direction of conducting tobacco control 
education. Other difficulties include the inten‑
sive advertising and promotion carried out by to‑
bacco companies, as well as early tobacco initia‑
tion and high social tolerance for tobacco smok‑
ing among youth.
Regulations related to the control of tobacco 
product use represent an important element of 
the strategy to reduce the health and the socio‑
‑economic consequences of tobacco smoking. 
However, good legislation in health care will 
not suffice to improve the health situation in 
the country unless it causes changes in the so‑
cial behavior of the citizens. It must be stressed 
that such actions should be supported by infor‑
mation and educational campaigns.
In conclusion, the current knowledge on cig‑
arette smoking and the results presented in this 
paper should support the antitobacco strategy. 
The prevalence of tobacco smoking in Poland, de‑
spite its downward trend, is still high. Significant 
smoking differentiation was observed depending 
on age. Most smokers were middle ‑aged people. 
During the follow‑up, the number of cigarettes 
smoked daily per smoker decreased. The rising 
tendency to quit smoking among men and wom‑
en is favorable, but the follow‑up showed a down‑
ward trend. The later start of smoking is also fa‑
vorable. The current activities in the field of to‑
bacco use control in Poland need strengthening 
in a few areas, including tobacco use monitoring, 
support in tobacco cessation, fiscal policy, as well 
as education and alerting the citizens to the haz‑
ards associated with the smoking habit.50
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